These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20549454)

  • 1. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.
    Tateishi A; Matsushita M; Asai T; Masuda Z; Kuriyama M; Kanki K; Ishino K; Kawada M; Sano S; Matsui H
    Gen Thorac Cardiovasc Surg; 2010 Jun; 58(6):265-70. PubMed ID: 20549454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.
    Yamamoto F; Yamamoto H
    Gen Thorac Cardiovasc Surg; 2010 Jun; 58(6):263-4. PubMed ID: 20549453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
    Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
    Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
    Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
    Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
    Deres L; Bartha E; Palfi A; Eros K; Riba A; Lantos J; Kalai T; Hideg K; Sumegi B; Gallyas F; Toth K; Halmosi R
    PLoS One; 2014; 9(7):e102148. PubMed ID: 25014216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.
    van de Schans VA; van den Borne SW; Strzelecka AE; Janssen BJ; van der Velden JL; Langen RC; Wynshaw-Boris A; Smits JF; Blankesteijn WM
    Hypertension; 2007 Mar; 49(3):473-80. PubMed ID: 17210832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest.
    Wang JS; Wang CL; Wen JF; Wang YJ; Hu YB; Ren HZ
    World J Gastroenterol; 2008 Jul; 14(25):3982-9. PubMed ID: 18609681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart.
    Weng YC; Chuang CF; Chuang ST; Chiu HL; Kuo YH; Su MJ
    Eur J Pharmacol; 2012 Jun; 684(1-3):108-15. PubMed ID: 22484506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
    Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
    J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
    Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
    Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
    Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.
    Deng J; Wang YW; Chen WM; Wu Q; Huang XN
    Biol Pharm Bull; 2010; 33(4):631-5. PubMed ID: 20410597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
    Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
    Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
    Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary artery smooth muscle hypertrophy: roles of glycogen synthase kinase-3beta and p70 ribosomal S6 kinase.
    Deng H; Hershenson MB; Lei J; Anyanwu AC; Pinsky DJ; Bentley JK
    Am J Physiol Lung Cell Mol Physiol; 2010 Jun; 298(6):L793-803. PubMed ID: 20190034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
    Kaga S; Zhan L; Altaf E; Maulik N
    J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.